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Experimental results are presented for 180 in silico designed octapeptide sequences and their stabilizing eﬀects on the major
histocompatibility class I molecule H-2K
b. Peptide sequence design was accomplished by a combination of an ant colony
optimization algorithm with artiﬁcial neural network classiﬁers. Experimental tests yielded nine H-2K
b stabilizing and 171
nonstabilizing peptides. 28 among the nonstabilizing octapeptides contain canonical motif residues known to be favorable for
MHC I stabilization. For characterization of the area covered by stabilizing and non-stabilizing octapeptides in sequence space, we
visualized the distribution of 100,603 octapeptides using a self-organizing map. The experimental results present evidence that the
canonical sequence motives of the SYFPEITHI database on their own are insuﬃcient for predicting MHC I protein stabilization.
1.Introduction
Cell surface presentation of peptides by major histocompat-
ibility complex I (MHC I) is prerequisite for the initiation
of an adaptive immune response [1] and knowledge of
MHC-binding peptides is required for the development
of vaccines and immunomonitoring protocols for cell-
mediated immunity. MHC I molecules are integral mem-
brane proteins that bind peptides with a length of eight
up to thirteen amino acids for presentation to CD8+ T
lymphocytes [2, 3]. Peptide binding to MHC I stabilizes
the MHC-peptide structure at the cell surface of antigen
presenting cells. Binding of an octapeptide to an MHC I
molecule is deﬁned by the recognition of the peptide by the
MHC molecule and its binding aﬃnity [4]. In consequence
the binding of the octapeptide leads to stabilization of the
MHC-peptide complex on the cell surface. Complex stability
is critically inﬂuenced by the amino acid sequence of the
bound peptide [5], for which Rammensee and coworkers
suggested allele-speciﬁc canonical sequence motifs [3]. For
the octapeptides presented by the mouse MHC I H-2Kb
this sequence motif (the canonical or SYFPEITHI motif)
is deﬁned as X-X-(Y)-X-[Y/F]-X-X-[L, M, I, V]. Positions
three,ﬁve,andeightarealsoreferredtoas“anchorpositions”
[6].
ForcharacterizationoftheH-2Kb stabilizingandnonsta-
bilizing sequence space we designed a diverse set of octapep-
tides. To explore extensions and alternatives to the known
canonical motif, the set of designed octapeptides included
sequences containing the full, partial, or no canonical
motif. To generate new octapeptides that stabilize H-2Kb we
applied an Ant Colony Optimization (ACO) [7] algorithm
in combination with neural network classiﬁers. Artiﬁcial
neural networks (ANNs) [8] were trained using a set of
423 octapeptides with known H-2Kb stabilizing eﬀect as
determined in cellular stabilization assays [9]. The resulting2 Journal of Biomedicine and Biotechnology
machine learning classiﬁers served as ﬁtness function for
the ACO algorithm. Navigation through sequence space
containing 208 possible octapeptides was realized by the
ACO meta-heuristic which is deduced from social insect
behavior [7, 10]. ACO is a probabilistic technique that is
not susceptible to dominant ultimate solutions but, due to
its “swarm intelligence” based on numerous autonomous
agents, open for broad and distributed optimization [11].
New peptide sequences were generated with the ACO
algorithm and presented to the trained ANNs for ﬁtness
evaluation. During this optimization process the peptide
sequences were iteratively adapted according to the ANN
ﬁtness score. Finally, the designed octapeptides were synthe-
sized and their stabilization eﬀect was tested experimentally.
Wepresentevidencethatrationalpeptidedesignutilizing
A C Oi sf e a s i b l ea n dl e a d st on o v e lb i o a c t i v ep e p t i d e sw i t h
minimal experimental eﬀort. Here, the focus is on the de
novo design of peptides with a speciﬁc MHC I stabilization
eﬀect. While some of the designed peptides conform to the
known canonical motif for H-2Kb stabilizing peptides, we
also show that the degree to which the peptide sequence
matches the motif alone is insuﬃcient for prediction of
MHCIstabilization.Wedesignedpeptideswiththecomplete
canonical sequence motif but lacking detectable stabilizing
eﬀect. For visualization of the transition between stabilizing
and nonstabilizing octapeptides we present a projection of
peptide sequence space on a self-organizing map (SOM).
This form of representation facilitates the identiﬁcation of
clusters of stabilizing peptides based on their physicochemi-
cal properties.
2.MaterialsandMethods
2.1. Data Set. Training data were compiled from the public
databases (AntiJen [12], EPIMHC [13], IEDB [14], MHCBN
[15]) and literature sources [16, 17]. The complete dataset
contained 423 octapeptides with 242 positive (stabilizing)
and 181 negative (nonstabilizing) examples. The annotation
of octapeptides as stabilizing and nonstabilizing mouse
MHC I protein H-2Kb was based on published experimental
data. EC50 values below 10µM were regarded as H-2Kb
stabilizing, greater EC50 values as nonstabilizing.
2.2. Sequence Encoding. Each residue of an octapeptide
was encoded by ﬁve diﬀerent sets of molecular descriptors
(See supplementary material (Suppl. 1) available online at
doi:10.1155/2010/396847) . The combination of amino acid
descriptors served as input for the ANNs. The dimension of
the input originated from the coding of each amino acid of
the octapeptide by each descriptor.
2.3. The Ant Colony Optimization. The ACO algorithm
was implemented using the Java programming language
V.1.6 (Sun Microsystems, Inc., Santa Clara, CA, USA).
Our ACO algorithm is deﬁned by three consecutive steps:
sequence design, path evaluation, and pheromone update,
as previously described by J¨ ager et al. [18]. Peptide design
by ACO was terminated when the pheromone concentration
had been constant for 10,000 iterations. Together the three
steps represent a single iteration of the algorithm (one
generation of ants). Ants are computational agents with
individual memory coded via “pheromone concentrations”.
While moving through the search space each ant generates
a path corresponding to a new octapeptide. All ants of one
generation move independent of each other on individual
paths. The resulting paths were evaluated by a ﬁtness
function implemented as ANNs. Communication between
subsequent generations of ants is achieved through the
modiﬁcation of pheromone concentrations (“stigmergy”
[19, 20]). The pheromone matrix represents the collective
memory of an ant colony. Only the path with the highest
ﬁtness obtained a pheromone update. The advantage of
the ACO algorithm is that agents need no information
about the complete problem to propose a solution, in our
case the complete possible sequence space containing 208
octapeptides.
2.4. Artiﬁcial Neural Network Fitness Function. Fully con-
nected feedforward networks with a single hidden layer and
one output neuron (all neurons with sigmoidal activation)
were implemented using Matlab (version 7.4.0.287 R2007a,
The Mathsworks Inc.; neural networks toolbox version
5.0.2). The outputs of ﬁve ANNs were combined as input
for a jury network [21]. The output of the jury served as
ﬁtness value (or “score”) for the ACO algorithm, which
adopted values of the interval ]0,1[. Details on the network
architecture were described previously [17].
2.5. Stabilization Assay. The stabilization assay was per-
formed as described by Brock et al. [9] using TAP-deﬁcient
RMA-S cells (mutagenized Rauscher virus-induced T lym-
phoma cells of mouse origin) [22]. The cells were cultured
in DMEM (Gibco-BRL, Karlsruhe, Germany) with 10%
FCS (Sigma-Aldrich, Steinheim, Germany) at 37
◦Cw i t h
8% CO2. For accumulation of peptide-free MHC I proteins
at the cell surface, the cells were cultured for 16 hours at
26
◦C. The cells were incubated with the peptides in 10 serial
dilutions of 100 to 5.6 × 10
−4µg/mL at room temperature
for 1 hour, followed by 1-hour incubation at 37
◦Cf o rd e n a t -
uration of peptide-free MHC I proteins. The stabilized MHC
I proteins were visualized and quantiﬁed by ﬂow cytometry
using the H-2Kb speciﬁc monoclonal antibody B8.24.3
[23] puriﬁed in the laboratory from hybridoma culture
supernatant by protein G aﬃnity chromatography (Pierce,
Darmstadt, Germany) and an R-Phycoerythrin-conjugated
anti-mouseantibody(DianovaGmbH,Hamburg,Germany)
as secondary reagent. The stabilizing eﬀect of the peptides
was determined as mean ﬂuorescence intensity (MFI). The
EC50 value is the peptide concentration that is required for
half-maximal stabilization of the MHC I molecules at the
cell surfaces (half-maximal MFI). All peptides were custom-
synthesized by EMC microcollections GmbH (T¨ ubingen,
Germany).
2.6. SYFPEITHI Score (S-Score). The S-score was calculated
using the public web server at URL: http://www.syfpeithi.de/Journal of Biomedicine and Biotechnology 3
(version July 2009). The S-score [6] indicates how well a
peptide sequence matches the canonical motif.
2.7. IEDB-ANN Score. For calculation of the Immune Epi-
tope Database- (IEDB-)ANN score the public web server at
URL: http://tools.immuneepitope.org/analyze/html/mhc
binding.html (version 2009-09-01) was used. IEDB oﬀers
several prediction tools for peptide binding to MHC I
m o l e c u l e s( a r t i ﬁ c i a ln e u r a ln e t w o r k s( A N N s ) ,a v e r a g er e l a -
tive binding (ARB), stabilized matrix method (SMM), SMM
with a peptide: MHC binding energy covariance matrix
(SMMPMBEC), scoring matrices derived from combinato-
rial peptide libraries (comblib sidney2008), consensus) [24].
The IEBD-ANN method [25] was chosen because it has been
determined to be qualitatively best performing [26]. The
IEDB-ANN scores are predicted IC50 values.
2.8. Self-Organizing Map (SOM). For visualization of the
peptide distribution in a high-dimensional descriptor space
we used planar SOMs [27] as implemented in the molmap
software package [28, 29]. The trained SOM performs a
nonlinear mapping from the original descriptor space onto a
two-dimensional map. Each data point is assigned to one of
a deﬁned number of receptive ﬁelds (neurons) of the SOM.
SOM training was performed as described previously [30].
3. Results andDiscussion
We report the design and examination of 180 octapeptides
(Table 1; Suppl. 2) in a cellular MHC I stabilization assay.
The ability of an octapeptide to stabilize MHC I was
speciﬁed as EC50 value, which is deﬁned as the peptide
concentration required for half-maximal stabilization of the
MHC I proteins at the cell surface by the test peptide. Nine
of the in silico designed octapeptides exhibited a stabilizing
eﬀect (Table 1, Seq. 1–9), and 171 were nonstabilizing
(Table 1, Seq. 10–50; Suppl. 2, Seq. 51–180). Six of the
nine stabilizing octapeptides had EC50 values below 10µM
(Table 1, Seq. 4–9) (i.e., strong MHC I stabilization). Three
octapeptides (Table 1, Seq. 1–3) can be regarded as medium
stabilizers(EC50 >20µM),twoofwhichcompletelymatched
the canonical motif (Table 1, Seq. 1 and 2) with EC50 values
of 24µMa n d2 0 µM. Six of the nine octapeptides that
correspond to the canonical motif in only two of the three
anchor positions yielded EC50 values below 10µM. Peptide
3h a da nE C 50 of 25µM. Peptide 8 (WKFIFDPV) conforming
to the SYFPEITHI motif in two positions (underlined) was
the most potent peptide with an EC50 of 0.4µM. Peptide 9
(FHHAHRTV) obeys the canonical motif in just one anchor
position but was still among the best stabilizers with an EC50
value of 9µM.
The SYFPEITHI score (S-score) is used as a computed
index for prediction of stabilizing abilities of peptides for
speciﬁc MHC molecules [6]. A high value indicates strong
stabilizing eﬀects. The S-score for the positive control in
our experiments (SIINFEKL from ovalbumin [4]) is 25. The
S-score of a known nonstabilizing octapeptide (LSPFPFDL
an endogenous MHC I H2-Ld epitope [31]) is 13. The
computed S-scores for the nine stabilizing octapeptides were
between 8 and 27 (mean = 20 ±6) reﬂecting their stabilizing
eﬀect (outlier: octapeptide 9 with an S-score of 8). Peptides
4, 5, and 7, while exhibiting EC50 values similar to sequence
9( E C 50 = 9µM), have more than two times greater S-
scores (S-score = 22, S-score = 20, S-score = 17 (Table 1, Seq.
4, 5, 7)). A possible explanation for the deviation between
the SYFPEITHI score and the actual binding behavior could
be the anchor position assignment. Sequences 4, 5, and 7
completelyfulﬁllthecanonicalmotifwhilesequence9fulﬁlls
it in only one position. Thus the degree of correspondence
to the canonical motif is well represented by the S-score but
does not necessarily reﬂect the actual binding behavior. This
suggests that alternative sequence motifs might confer strong
stabilization eﬀects or that the binding motive concept needs
to be extended.
We then compared our experimental results to pre-
dictions of the Immune Epitope Database (IEDB) [24].
The database oﬀers several prediction methods of which,
according to Peters et al. [26], IEDB-ANN [25] is the best
performing. For the nine binding peptides found by us, the
Pearson correlation [32] between the IC50 values predicted
by IEDB-ANN for mouse H2-Kb and our measured EC50
values is −0.34, which indicates moderate negative correla-
tion. Using the activity cutoﬀ of IC50 < 500nM for “medium
activity”[25],theIEDB-ANNmethodcorrectlypredictsfour
of nine sequences as binding peptides (Table 1,S e q .1 – 3 ,6 ) .
The remaining 171 octapeptides showed no detectable
stabilizing eﬀect at a maximal experimental peptide con-
centration of 100µg/mL and were therefore deﬁned as
nonstabilizing (Table 1, Seq. 10–50; cf. Suppl. 2, Seq. 51–
180). The nonstabilizing octapeptides can be grouped into
four categories according to the degree of fulﬁllment of the
canonical SYFPEITHI motif:
Category (i): three canonical anchor amino acids: 12
octapeptides (Table 1, Seq. 10–21),
Category (ii): two canonical anchor amino acids: 16
octapeptides (Table 1, Seq. 22–37),
Category (iii): one canonical anchor amino acid: 23
octapeptides (Table 1, Seq. 38–42; Suppl. 2, Seq. 50–
68),
Category (iv): no canonical anchor amino acids: 120
octapeptides (Table 1, Seq. 42–50; Suppl. 2, Seq. 69–
180).
Foroctapeptidesofcategory(i)highS-scoreswerecomputed
in the range between 22 and 28 (mean = 25 ± 2) suggesting
a stabilizing ability of the octapeptides. In comparison to
the S-scores of the nine stabilizing octapeptides, category (i)
sequenceshadhigherS-scoresthuserroneouslypredictingan
evenstrongerMHC Istabilizing eﬀect.Category (ii)peptides
obtained a mean S-score of 19 ± 2 still indicating possible
MHC I stabilization. Notably, none of these octapeptides
had a stabilizing eﬀect in our experiments. The S-scores of
category (iii) peptides (mean = 11±2) are in agreement with
the lack of a stabilizing eﬀect. For category (iv) peptides the
computed S-scores (mean = 1 ± 1) perfectly agreed with the
experimental results obtained for these 120 sequences.4 Journal of Biomedicine and Biotechnology
Table 1:Experimentallytestedoctapeptides.Sequencesaregiveninsingle-lettercode;motifanchorpositionsfulﬁllingtheSYFPEITHImotif
areunderlined.S-score:SYFPEITHIscore[6].IEDB-ANNscore:predictedIC50 valuesbyIEDB-ANNmethod[25].<500nM:recommended
cutoﬀ for IEDB-ANN score [25] for binders predicted with intermediate aﬃnity; active: IEDB-ANN score <500nM; 0: IEDB-ANN score
>500nM. EC50 values correspond to the peptide concentration required for 50% of maximal MHC I protein stabilization; values in brackets
are standard deviations (N = 3). n.d.: not detectable.
Peptide number Sequence S-score IEDB-ANN
score [µM]
<500nM Experimental
EC50 [µM]
Stabilizing peptides
1 FRYPYKTL 27 0.5 active 24.0 (±11)
2 FRYIYHTL 27 0.2 active 20.0 (±4.0)
3 FHWDYRGL 22 0.4 active 25.0 (±11)
4 WRFKYDNL 22 2.3 0 7.0 (±4.0)
5 WRFVYWRL 20 1.2 0 8.0 (±4.0)
6 WRFIYFNL 21 0.4 active 3.6 (±1.2)
7 WDFKFDSV 17 4.7 0 9.0 (±4.0)
8 WKFIFDPV 16 3.0 0 0.4 (±0.1)
9 FHHAHRTV 8 10.5 0 9.0 (±4.0)
Nonstabilizing peptides of
category (i)
10 FRYEYRSL 28 0.1 active n.d.
11 WRYIYHSI 22 2.5 0 n.d.
12 HRYVYRNI 24 0.4 active n.d.
13 FHYAYRSV 23 0.1 active n.d.
14 YRYKYDRL 27 0.5 0 n.d.
15 WRYQYDNL 27 0.7 0 n.d.
16 WRYRYWSL 27 0.6 0 n.d.
17 WRYNYDPL 26 1.7 0 n.d.
18 WRYHYDPL 26 2.4 0 n.d.
19 WKYQYDNL 27 0.3 active n.d.
20 WKYIFDPV 22 1.2 0 n.d.
21 WKYPFDPV 22 2.0 0 n.d.
Nonstabilizing peptides of
category (ii)
22 FRYLYKNA 17 1.2 0 n.d.
23 FRYVWRTL 18 1.7 0 n.d.
24 FHYLYHTA 17 0.9 0 n.d.
25 FRYPYHTP 17 17.8 0 n.d.
26 FRWEYRGL 22 0.7 0 n.d.
27 FRHIYRTI 18 9.3 0 n.d.
28 FRHGYRQI 18 12.6 0 n.d.
29 FHWAYHTV 17 1.2 0 n.d.
30 WRWLYKGV 16 4.3 0 n.d.
31 WRFPYDQL 21 6.6 0 n.d.
32 WRFKYDPL 21 3.3 0 n.d.
33 WRFPYDKL 21 6.8 0 n.d.
34 WRFVYDNL 21 1.9 0 n.d.
35 WKFKFDPV 17 2.8 0 n.d.
36 WKINFDPV 17 8.2 0 n.d.
37 TTEWYTKI 18 3.4 0 n.d.
5 of 23 nonstabilizing
peptides of category (iii)
38 RGEVFTAT 13 24.0 0 n.d.
39 FHYDHRNA 9 6.5 0 n.d.
40 HRWVFWQP 11 26.0 0 n.d.
41 SIKNFHYY 12 13.6 0 n.d.
42 FRHDYHSP 11 29.2 0 n.d.Journal of Biomedicine and Biotechnology 5
Table 1: Continued.
Peptide number Sequence S-score IEDB-ANN
score [µM]
<500nM Experimental
EC50 [µM]
7 of 120 nonstabilizing
peptides of category(iv)
43 TVEQGVTQ 1 37.5 0 n.d.
44 FHHGHNVP 0 36.8 0 n.d.
45 QDGHEIHR 1 38.4 0 n.d.
46 TVEQGVTQ 1 37.5 0 n.d.
47 GVDQSYLK 0 38.1 0 n.d.
48 SVENPILR 2 33.7 0 n.d.
49 NEGWTIHR 1 38.8 0 n.d.
50 SVDHSIFK 2 36.1 0 n.d.
For category (iii) 5 of 23 octapeptides are given as examples. The remaining 18 octapeptides of category (iii) are listed in Suppl. 2 (Seq. No. 51–68). For
category (iv) 7 of 120 ostapeptides are given as examples. The remaining 113 octapeptides of category (iv) are listed in Suppl. 2 (Seq. No. 69–180).
(a) (b)
S-Q-Y-Y-Y-N-S-L
(c)
Figure 1: Structural model of murine MHC I molecule H2-K
b with bound octapeptide SQYYYNSL. (a) Crystal structure model of H2-K
b
with bound octapeptide SQYYYNSL (PDB entry 2clv [33]). Top view of the peptide binding groove: red: alpha helices; yellow: beta sheets;
blue:o c t a p e p t i d eSQYYYNSL, amino acids of the anchor positions are shown as sticks. (b) Schematic side view of the peptide binding groove
with the bound octapeptide SQYYYNSL; Amino acid side chains at the anchor positions are shown as sticks. (c) The octapeptide SQYYYNSL
with boxed anchor positions of the canonical motif.
The IEDB-ANN method [25] predicts four sequences as
“binding”, which were determined as “nonbinding” in our
experiments (Table 1, category (ii), Seq. 10, 12, 13, 19). The
remaining 37 negative sequences are correctly predicted as
“nonbinding” (Table 1, categories (ii)–(iv)). Compared to
the S-score index, the IEDB-ANN method is better suited for
identifying nonbinding sequences that contain only a partial
canonical motif (categories (ii) and (iii)). Despite these
diﬀerences, both software tools (S-score and IEDB-ANN
method) can be recommended for identiﬁcation of negative
(inactive) sequences lacking the canonical motif (categories
(iii)–(iv)). Based on these limited data, quantitative IC50
predictions of binding/nonbinding peptides by this software
seem to be of limited accuracy but qualitative prediction is
acceptable.
The experimental results for the 180 designed octapep-
tides allowed us to reassess the canonical motif. We found
28 inactive octapeptides that conform to the motif in all
three (category (i)) or two residue positions (category (ii)).
This corroborates the results of Zhong et al. [16] reporting6 Journal of Biomedicine and Biotechnology
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Figure 2:Self-organizingmap(SOM)projectionofMHCIH2-K
b stabilizingpeptides.TheSOMwastrainedwith100,603octapeptides(603
peptides with known H-2K
b binding aﬃnity and 100,000 octamer sequences randomly generated according to the amino acid frequency of
M. musculus proteins). Only the distribution of the known stabilizing peptides is shown. The color of a neuron reﬂects its relative occupancy
(white: empty; light blue: slightly occupied; dark blue: most occupied). (a) Distribution of the known 251 H-2K
b stabilizing octapeptides.
(b) Distribution of 80 stabilizing octapeptides with amino acid sequences corresponding to the canonical motif in all three anchor positions.
(c) Distribution of 152 stabilizing octapeptides with amino acid sequences corresponding to the canonical motif in two residue positions.
onenonstabilizing octapeptide withthecanonicalmotif, and
Hiss et al. [17] reporting four nonstabilizing octapeptides
corresponding to the motif. Our data suggest that the
canonical motif alone is insuﬃcient for predicting MHC I
stabilization. Octapeptides stabilize the MHC I molecules by
binding into the peptide binding groove which is framed by
two alpha helices on top of a eight-stranded beta sheet [2]
(Figure 1(a)). Amino acids at sequence position three and
ﬁve, favorably tyrosine or phenylalanine, can form aromatic
interactions with MHC I residues facing the binding groove
(Figure 1(b)), which could explain why canonical occupancy
often corresponds to stabilizing peptides [34]. In addition,
the aliphatic residue at position eight interacts with aliphatic
amino acids in a deep pocket of the MHC I peptide binding
canyon (Figure 1(b)). Octapeptides that conform completely
to the canonical motif but show no stabilizing eﬀect indicate
that other amino acids besides the three anchor residues are
important for the stabilizing eﬀect. Amino acids at nonmotif
positions could interfere with the favorable eﬀects of the
three anchor residues and lead to a nonstabilizing peptide.
To visualize the distributions of stabilizing and nonsta-
bilizing octapeptides, we trained a SOM [28, 29]t oo b t a i n
a two-dimensional map of the peptide distribution. The
SOM represents the peptides based on their physicochemical
properties coded by a multidimensional vector. Adjacent
regions of a given peptide on the SOM represent peptides
with similar physicochemical properties. The SOM was
trained with a total of 100,603 octapeptides. We randomly
generated100,000octamersequencesaccordingtotheamino
acid frequency found in known mouse proteins to mimicJournal of Biomedicine and Biotechnology 7
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Figure 3: Self-organizing map (SOM) projection of MHC I stabilizing peptides. The SOM was trained with 100,603 octapeptides (603
peptides with known H-2K
b binding aﬃnity and 100,000 octamer sequences randomly designed according to the amino acid frequency of
M. musculus proteins). Neurons are colored according to the MHC I stabilizing ability of the octapeptides (red: nonstabilizing; blue: mixed;
green: stabilizing). (a) Projection of the known 251 stabilizing octapeptides and 24 nonstabilizing octapeptides with amino acid sequences
corresponding to the canonical motif in all three positions. (b) Projection of the known 251 stabilizing octapeptides and 93 nonstabilizing
octapeptides with amino acid sequences corresponding to the canonical motif in two positions. (c) Projection of the known 251 stabilizing
octapeptides and 59 nonstabilizing octapeptides with amino acid sequences corresponding to the canonical motif in only one position.
murine sequence space. For the remaining 603 octapeptides
the H-2Kb binding aﬃnities were known from published
experimental data (training data set: 423 octapeptides with
242 stabilizing and 181 nonstabilizing peptides and own
experimental results: 180 octapeptides with 9 stabilizing and
171 nonstabilizing peptides). The 251 octapeptides with
H-2Kb binding aﬃnity are highlighted on the trained SOM
presented with Figure 2(a). It is noteworthy that 241 of
the 251 stabilizing peptides form a “stabilizing cluster” on
the map (neurons 9–11/0, 9-10/1, 9-10/2), which indicates
that these peptides are more similar to each other than to
the randomly generated octapeptides. The highest density
of stabilizing peptides is located in neuron (9/1) which
contains 180 sequences. The outlier neuron (1/15) contains
octapeptide 9 (FHHAHRTV), a stabilizing octapeptide with a
canonical residue in only one anchor position.
The distribution of stabilizing octapeptides fulﬁlling the
canonical motif in all three anchor positions (80 sequences)
is presented in Figure 2(b). All 80 octapeptides are located
in a “stabilizing cluster”. Of the 152 sequences complying
in only two anchor positions with the canonical motif
145 are located in this “stabilizing cluster” (Figure 2(c)).
The remaining seven of the 152 sequences, which are not
located in the “stabilizing cluster”, are located in neurons8 Journal of Biomedicine and Biotechnology
framing the “stabilizing cluster”. The canonical motif is thus
overrepresented in the “stabilizing cluster”. Although the
known active octapeptide sequences constitute an island
on the SOM implying similar physicochemical properties,
our experimental results suggest that the canonical motif
represents only a, albeit maybe dominant, fraction of the
MHC I stabilizing sequences (Table 1, Seq. 10–21).
The SOM presented in Figures 3(a)–3(c) presents the
distribution of sequences containing only stabilizing (green),
only nonstabilizing (red), or containing both stabilizing and
nonstabilizing octapeptides (blue). The locations of all 251
stabilizing octapeptides are shown; Figure 3(a) additionally
includescategory(i)nonstabilizingoctapeptides,Figure3(b)
category (ii), and Figure 3(c) category (iii) peptides. The
majority (54%) of the nonstabilizing octapeptides of cate-
gory (i) (24 sequences) is located in neurons surrounding
the “stabilizing cluster”, implying similarity in terms of
the peptide representation by physicochemical properties
(Figure 3(a)). Notably, the three neurons (9/1), (10/2), and
(11/0) also contain nonstabilizing peptides (blue-colored
neurons). Four motif-conform nonstabilizing octapeptides
(WRYNYDPL,FRYEYRSL,HRYVYRNI,YRYKYDRL) are located
in neuron (9/1) which contains the highest number of
stabilizing octapeptides (180 sequences). The remaining
(46%) nonstabilizing octapeptides of category (i) populate
the lower left quadrant of the SOM. As illustrated in
Figure 3(b), this area becomes more densely occupied when
the 93 octapeptides of category (ii) are included: 75% of
these peptides are located in this area of the SOM. Only two
sequences of category (ii) can be found in the “stabilizing
cluster”: FRYVWRTL and TTEWYTKI (neurons (9/0) and
(9/1), Figure 3(b)). Apparently, category (iii) octapeptides
are scattered in sequence space (Figure 3(c)). Only one
nonstabilizing octapeptide of this category can be found in
the “stabilizing cluster” (neuron (10/0), Figure 3(c)).
In summary, we have identiﬁed nine stabilizing octapep-
tides, two of which conform to the canonical motif in all
three anchor positions, six fulﬁll two anchor requirements,
and one sequence complies with the canonical motif in
just one position. The majority of the designed and tested
octapeptides (171 sequences) had no MHC I stabilizing
eﬀect. Twelve of the nonstabilizing octapeptides completely
conform to the canonical motif, and sixteen fulﬁll the motif
at two anchor positions. 23 octapeptides comply with the
canonical motif at one residue position and exhibit no
stabilizing eﬀect. The remaining 120 octapeptides share no
residue position with this motif. Since the experimental
results reported here were not included in the SOM training,
the resulting map provides a physicochemically deﬁned
distribution of stabilizing and nonstabilizing octapeptides
in sequence space. Apparently, the stabilizing octapeptides
constitute an island in octapeptide sequences space. Still,
nonstabilizing octapeptides are colocated in this area. These
nonstabilizing samples fulﬁll three or two residue positions
of the canonical motif. The SOM clusters stabilizing peptides
in a section of sequence space with similar physicochemical
properties. A hint towards additional stabilizing clusters
could be sequence 9 which is not clustered together with the
other stabilizing peptides. Furthermore, neurons adjacent
to the “stabilizing cluster” also contain MHC I stabilizing
sequences, which indicates that the epitope motif concept
need to be extended in order to cover and predict alternative
stabilizing peptides.
4. Conclusions
Our study conﬁrms and extends the epitope motif concept
for MHC-binding peptides proposed by Rammensee and
coworkers [6]. We found octapeptides that lack key anchor
residues but still exhibit a pronounced MHC I stabilization
ability well comparable to peptides that fully conform to
the canonical sequence motif. We also present a number of
motif-conform but nonstabilizing peptides. This two ﬁnd-
ings clearly demonstrate that the canonical sequence motif
alone is no suﬃcient criterion for the MHC I stabilizing
peptides.
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